These days, a lot of embedded projects feature some sort of screen, and a screen often creates a desire for a nice user interface. [Geoffrey Wells] has created a tool for developing web interfaces for ...

The number of people with electrodes in their brains is believed to have more than doubled in the last couple of years. This week, I covered the story of Casey Harrell—a man with ALS who is “the first ...

Deploy Qt Creator Gui to build cross-platform software, optimize interfaces using Qt Designer Python, and manage layouts with Pyqt Gui Designer tools. The Qt Creator Gui framework establishes a ...

It might soon be “game over” for the video game controller. Yale researchers have developed a new kind of brain-computer interface (BCI) that lets humans play video games directly with their brains.

VentureBeat made with Google Gemini 3.1 Pro Image The transition from AI as a chatbot to AI as a workforce is no longer a theoretical projection; it has become the primary design philosophy for the ...

Every capability in Salesforce’s platform is accessible via application programming interfaces, Model Context Protocol tools for connecting models to data and tools, or the command line. That means ...

Windows development has always been complex, but new insights from a former Microsoft executive shed light on just how fragmented it became. Jeffrey Snover, speaking about the platform’s history, ...

OpenAI is planning to unify its ChatGPT app, coding platform Codex and browser into a desktop “superapp,” a step to simplify the user experience and continue with efforts to focus on engineering and ...

Once upon a time, the portal concept promised to give every user a personalized view. Finally, the promise of a web where the user was also the controller could be realized. That didn’t quite work out ...

Emily Day is an experienced researcher, writer, and editor with expertise in geopolitics, nuclear energy, and global security. She is an associate editor of Energy World and Techland at The National ...

The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. The proposal is designed to incentivize U.S. drug development by tacking on ...